Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Regression of sight-threatening macular edema in type 2 diabetes following treatment with the anti-tumor necrosis factor monoclonal antibody infliximab.

× No keyword cloud information.

28 in total

Review 1. Immunological mechanisms in the pathogenesis of diabetic retinopathy.

Authors: Anthony P Adamis; Adrienne J Berman
Journal: Semin Immunopathol Date: 2008-03-14 Impact factor: 9.623

2. Novel Pharmacologic Approaches for the Management of Diabetic Retinopathy.

Authors: Jaclyn L Kovach; Stephen G Schwartz
Journal: Mol Cell Pharmacol Date: 2009-01-01

Review 3. Current approaches to the management of diabetic retinopathy and diabetic macular oedema.

Authors: Francesco Boscia
Journal: Drugs Date: 2010-11-12 Impact factor: 9.546

4. Angiogenic Factors and Cytokines in Diabetic Retinopathy.

Authors: Steven F Abcouwer
Journal: J Clin Cell Immunol Date: 2013

Review 5. Müller cells and diabetic retinopathy.

Authors: Brandon A Coughlin; Derrick J Feenstra; Susanne Mohr
Journal: Vision Res Date: 2017-09-05 Impact factor: 1.886

6. Combined inhibition of tumor necrosis factor (TNF) and vascular endothelial growth factor (VEGF) for the treatment of macular edema of various etiologies: a short-term pilot study.

Authors: J F Arevalo; M A Serrano; L Wu
Journal: Eye (Lond) Date: 2013-01-18 Impact factor: 3.775

Review 7. Diabetic complications and dysregulated innate immunity.

Authors: Dana T Graves; Rayyan A Kayal
Journal: Front Biosci Date: 2008-01-01

8. Intravitreal administration of the anti-TNF monoclonal antibody infliximab in the rabbit.

Authors: Panagiotis G Theodossiadis; Vasilios S Liarakos; Petros P Sfikakis; Alexander Charonis; Georgios Agrogiannis; Nikolaos Kavantzas; Ioannis A Vergados
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2008-11-04 Impact factor: 3.117

9. Regression of macular edema secondary to branch retinal vein occlusion during anti-TNF-alpha therapy for rheumatoid arthritis.

Authors: Shu Kachi; Kenshin Kobayashi; Hiroaki Ushida; Yasuki Ito; Mineo Kondo; Hiroko Terasaki
Journal: Clin Ophthalmol Date: 2010-07-30

10. Infliximab for diabetic macular edema refractory to laser photocoagulation: a randomized, double-blind, placebo-controlled, crossover, 32-week study.

Authors: Petros P Sfikakis; Vlassis Grigoropoulos; Ioannis Emfietzoglou; George Theodossiadis; Nicholas Tentolouris; Evi Delicha; Christina Katsiari; Kleopatra Alexiadou; Erifili Hatziagelaki; Panayiotis G Theodossiadis
Journal: Diabetes Care Date: 2010-04-22 Impact factor: 17.152